Prospective Assessment of TBDx Feasibility
NCT02912832
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
572
Enrollment
OTHER
Sponsor class
Conditions
Pulmonary Tuberculosis
Interventions
DEVICE:
TBDx
Sponsor
Foundation for Innovative New Diagnostics, Switzerland